The New York State Office of Cannabis Management (OCM) released a statement declaring it had filed charges against cannabis processor and distributor Omnium Health (Omnium Canna) and had issued a statewide recall of associated products (1). The statement was released by the OCM on Monday, October 20, 2025.

Notice of Pleading Issued by NY OCM

In the press release, the OCM explains it has issued a Notice of Pleading (NOP), claiming Omnium had enabled an operation allowing unlicensed businesses to use its processing and distribution license to produce and package cannabis to state retailers. The NOP is alleging multiple violations from Omnium including aiding and abetting unlicensed processing, material misrepresentation, and failure to disclose substantial changes in business operations.

The actions allowed unlicensed business access to the regulated cannabis industry, damaging its integrity, the OCM added. “I have heard so many in New York cannabis call for fairness at every level,” said Felicia A. B. Reid, Executive Deputy Director of the Office of Cannabis Management. “Omnium’s alleged conduct is a blatant breach of the licensing rules designed to ensure transparency and fairness in the legal market. Our State’s cannabis laws are clear: licenses are not transferable and only licensed operators may produce and distribute cannabis. OCM’s move today ensures that regulated businesses do not exploit loopholes or take advantage to undermine legal operators who play by the rules.”

Investigation into Alleged Reverse Licensing

In February 2025, the OCM began its investigation after receiving a referral to the OCM Trade Practices Bureau (TPB) from the Compliance team. The investigation included reviewing audit and inspection records, reviewing Omnium and the unlicensed businesses’ contracts and audits, and collecting witness testimony. The OCM press release included photos of products and isolate allegedly involved in the operation.